ask="21.85"
ask_size="100"
average_daily_volume="226905"
bid="12.15"
bid_size="100"
book_value="8.77"
change="+2.25"
change_from_200_day_moving_average="3.89"
change_from_50_day_moving_average="5.63"
change_from_52_week_high="-4.73"
change_From_52_week_low="8.55"
change_in_percent="+12.00%"
close="21.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.87"
ebitda="-80.96M"
eps_estimate_current_year="-4.10"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-4.02"
ex_dividend_date="N/A"
float_shares="10433000"
high="21.25"
high_52_weeks="25.73"
last_trade_date="3/10/2017"
last_trade_price="21.00"
last_trade_size="15731"
last_trade_time="4:00pm"
low="18.75"
low_52_weeks="12.45"
market_capitalization="607.21M"
moving_average_200_day="17.11"
moving_average_50_day="15.37"
name="Atara Biotherapeutics
Inc."
notes="N/A"
one_year_target_price="25.60"
open="19.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+22.73%"
percent_change_from_50_day_moving_average="+36.64%"
percent_change_from_52_week_high="-18.38%"
percent_change_from_52_week_low="+68.67%"
previous_close="18.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.14"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28915000"
short_ratio="16.38"
stock_exchange="NMS"
symbol="ATRA"
volume="635577"
weeks_range_52="12.45 - 25.73"
